Ignite Creation Date:
2025-12-17 @ 5:06 PM
Ignite Modification Date:
2025-12-24 @ 5:57 AM
Study NCT ID:
NCT00725933
Status:
COMPLETED
Last Update Posted:
2017-01-09
First Post:
2008-07-29
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Administration of BIIB028 to Subjects With Solid Tumors
Sponsor:
Biogen
Organization:
Study Overview
Official Title:
A Phase 1, Multicenter, Open-Label, Dose Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of BIIB028 Administered to Subjects With Advanced Solid Tumors
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Safety and Tolerability of BIIB028
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: